Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion type Assertion NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_head.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion description "[As circulating chromogranin-A (CgA) levels are found to correlate with tumor progression and the status of hormone refractoriness, our current study attempted to assess whether CgA-positive cells would be preferentially distributed in epithelial structures with FBCLD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_provenance.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion evidence source_evidence_literature NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_provenance.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion SIO_000772 21980038 NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_provenance.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion wasDerivedFrom befree-20140225 NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_provenance.
- NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_assertion wasGeneratedBy ECO_0000203 NP651954.RAVa5jOg_Uw2207i8OR1OLO45QOGq6-l47xmskSy3_nq0130_provenance.